Contributor: Ricky Dhaliwal, MD, JD

Educational Pearls:

Tranexamic acid (TXA) as shown to have mortality benefit to patients with traumatic GI hemorrhage but should it be used to achieve hemostasis in atraumatic GI bleeding?
HALT-IT study looked at TXA for the treatment of upper and lower GI hemorrhage and found no 5 day mortality benefit
Patients given TXA also had higher occurrences of DVT and PE

References

Summarized by Jackson Roos, MS4 | Edited by Erik Verzemnieks, MD

David R. Hawkins | How to Surrender to God’s Will